Hapvida Participações e Investimentos

Telemedicine And AI Will Revolutionize Brazil's Healthcare

AnalystHighTarget

Not Invested

Consensus Narrative from 14 Analysts

Published

02 Jul 25

Updated

20 Aug 25

AnalystHighTarget's Fair Value

R$84.86

54.1% undervalued

20 Aug

R$38.94

-41.8%

3.7%

-41.8%

3.7%

Author's Valuation

R$84.9

54.1% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

R$84.9

54.1% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

7.86%

Healthcare Services revenue growth rate

0.26%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

18.09%

Calculation

R$3.40b

Earnings '28

20.67x

PE Ratio '28

R$70.19b

Market Cap '28

R$70.19b

Market Cap '28

510.25m

No. shares '28

R$137.57

Share Price '28

R$137.57 Share Price '28

Discounted to 2025 @ 18.11% p.a.

R$83.49

Fair Value '25